Literature DB >> 21588382

Vadimezan: 2-(5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid.

Shi-Jie Zhang1, Wei-Xiao Hu.   

Abstract

In the title mol-ecule, C(17)H(14)O(4), the C atom of the carboxyl group deviates by 1.221 (3) Å from the plane [maximum deviation = 0.0122(2) Å] of the tricycic ring system. In the crystal structure, inter-molecular O-H⋯O hydrogen bonds link the mol-ecules into centrosymmetric dimers, and π-π inter-actions [centroid-centroid distances = 3.491 (3), 3.591 (3), 3.639 (3) and 3.735 (3) Å] link these dimers into layers parallel to the ac plane. Weak inter-molecular C-H⋯O inter-actions further consolidate the crystal packing.

Entities:  

Year:  2010        PMID: 21588382      PMCID: PMC3007383          DOI: 10.1107/S1600536810028394

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For general background to and recent reviews of vascular-disrupting agents and the development of Vadimezan (DMXAA, ASA404), a promising small-mol­ecule tumor-vascular disrupting agent in phase III clinical trials, see: McKeage & Baguley (2010 ▶); Head & Jameson (2010 ▶); Ching (2008 ▶); Patterson & Rustin (2007 ▶); Hinnen & Eskens (2007 ▶); Lippert (2007 ▶). For a recent clinical study of Vadimezan, see: Pili et al. (2010 ▶); McKeage et al. (2008 ▶, 2009 ▶). For studies of the mol­ecular mechanisms and signal pathways of Vadimezan, see: Zhan et al. (2010 ▶); Cheng et al. (2010 ▶); Roberts et al. (2008 ▶). For the biological and pharmacological activity of Vadimezan analogues with structure–activity relationships, see: Gobbi et al. (2006 ▶); Woon et al. (2005 ▶). For the synthesis and spectroscopic data for Vadimezan, see: Yang & Denny (2009 ▶); Atwell et al. (2002 ▶). For related xanthone structures, see: Yu et al. (2008 ▶); Zhang et al. (2007 ▶).

Experimental

Crystal data

C17H14O4 M = 282.28 Triclinic, a = 6.7854 (19) Å b = 9.826 (3) Å c = 10.532 (3) Å α = 71.435 (7)° β = 82.741 (9)° γ = 83.142 (9)° V = 658.0 (3) Å3 Z = 2 Mo Kα radiation μ = 0.10 mm−1 T = 163 K 0.50 × 0.50 × 0.37 mm

Data collection

Rigaku AFC10/Saturn724+ diffractometer 6284 measured reflections 2955 independent reflections 2304 reflections with I > 2σ(I) R int = 0.018

Refinement

R[F 2 > 2σ(F 2)] = 0.040 wR(F 2) = 0.094 S = 1.00 2955 reflections 195 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.26 e Å−3 Δρmin = −0.17 e Å−3 Data collection: CrystalClear (Rigaku/MSC, 2008 ▶); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXL97 (Sheldrick, 2008 ▶); software used to prepare material for publication: publCIF (Westrip, 2010 ▶) and PLATON (Spek, 2009 ▶). Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536810028394/cv2747sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810028394/cv2747Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C17H14O4Z = 2
Mr = 282.28F(000) = 296
Triclinic, P1Dx = 1.425 Mg m3
a = 6.7854 (19) ÅMo Kα radiation, λ = 0.71073 Å
b = 9.826 (3) ÅCell parameters from 1944 reflections
c = 10.532 (3) Åθ = 3.0–27.5°
α = 71.435 (7)°µ = 0.10 mm1
β = 82.741 (9)°T = 163 K
γ = 83.142 (9)°Block, colorless
V = 658.0 (3) Å30.50 × 0.50 × 0.37 mm
Rigaku AFC10/Saturn724+ diffractometer2304 reflections with I > 2σ(I)
Radiation source: Rotating AnodeRint = 0.018
graphiteθmax = 27.5°, θmin = 3.4°
Detector resolution: 28.5714 pixels mm-1h = −8→8
phi and ω scansk = −11→12
6284 measured reflectionsl = −13→13
2955 independent reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.040Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.094H atoms treated by a mixture of independent and constrained refinement
S = 1.00w = 1/[σ2(Fo2) + (0.0346P)2 + 0.226P] where P = (Fo2 + 2Fc2)/3
2955 reflections(Δ/σ)max < 0.001
195 parametersΔρmax = 0.26 e Å3
0 restraintsΔρmin = −0.17 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/UeqOcc. (<1)
O10.21097 (13)0.40487 (9)0.72385 (9)0.0215 (2)
O20.36821 (16)0.20951 (10)0.43040 (10)0.0335 (3)
O30.49314 (15)0.35197 (11)0.95899 (10)0.0312 (2)
O40.23835 (16)0.47712 (12)1.03729 (11)0.0361 (3)
C10.3402 (2)0.03641 (14)0.70661 (15)0.0278 (3)
H10.3796−0.01440.64310.033*
C20.3195 (2)−0.03755 (15)0.84129 (16)0.0330 (3)
H20.3434−0.13950.87100.040*
C30.2632 (2)0.03676 (15)0.93484 (15)0.0306 (3)
H30.2494−0.01591.02790.037*
C40.2271 (2)0.18497 (14)0.89551 (14)0.0252 (3)
C50.18653 (18)0.63568 (13)0.56645 (13)0.0208 (3)
C60.20182 (18)0.72389 (13)0.43318 (13)0.0221 (3)
C70.25597 (19)0.66243 (14)0.32918 (13)0.0248 (3)
H70.26640.72330.23860.030*
C80.29413 (19)0.51639 (14)0.35551 (13)0.0238 (3)
H80.33010.47720.28330.029*
C90.32191 (19)0.26831 (14)0.51829 (13)0.0232 (3)
C100.30347 (19)0.18691 (14)0.66213 (13)0.0223 (3)
C110.24803 (18)0.25830 (13)0.75729 (13)0.0212 (3)
C120.22678 (17)0.48664 (13)0.59068 (12)0.0188 (3)
C130.28044 (18)0.42500 (13)0.48780 (13)0.0202 (3)
C140.1303 (2)0.69521 (15)0.68242 (14)0.0298 (3)
H14A0.12790.61590.76710.036*0.50
H14B−0.00200.74770.67340.036*0.50
H14C0.22840.76080.68230.036*0.50
H14D0.10840.80040.64810.036*0.50
H14E0.23820.66860.74180.036*0.50
H14F0.00780.65540.73300.036*0.50
C150.1628 (2)0.88493 (14)0.39994 (15)0.0291 (3)
H15A0.02750.90870.43620.035*
H15B0.17610.92920.30210.035*
H15C0.25940.92170.43990.035*
C160.1661 (2)0.26804 (15)0.99384 (14)0.0293 (3)
H16A0.14620.19911.08540.035*
H16B0.03690.32400.97200.035*
C170.3156 (2)0.36947 (15)0.99384 (13)0.0260 (3)
H4O0.345 (3)0.541 (2)1.032 (2)0.076 (7)*
U11U22U33U12U13U23
O10.0261 (5)0.0176 (4)0.0205 (5)−0.0008 (3)−0.0016 (4)−0.0061 (4)
O20.0449 (6)0.0277 (5)0.0326 (6)0.0000 (4)−0.0035 (5)−0.0171 (4)
O30.0298 (5)0.0314 (5)0.0339 (6)0.0002 (4)−0.0023 (4)−0.0133 (4)
O40.0322 (6)0.0397 (6)0.0430 (6)0.0003 (5)−0.0014 (5)−0.0241 (5)
C10.0279 (7)0.0212 (7)0.0377 (8)−0.0008 (5)−0.0081 (6)−0.0125 (6)
C20.0367 (8)0.0185 (7)0.0426 (9)−0.0008 (6)−0.0115 (7)−0.0053 (6)
C30.0334 (8)0.0252 (7)0.0295 (7)−0.0046 (6)−0.0071 (6)−0.0010 (6)
C40.0227 (7)0.0253 (7)0.0272 (7)−0.0041 (5)−0.0031 (5)−0.0063 (6)
C50.0184 (6)0.0207 (6)0.0249 (7)−0.0018 (5)−0.0017 (5)−0.0094 (5)
C60.0185 (6)0.0198 (6)0.0279 (7)−0.0021 (5)−0.0036 (5)−0.0063 (5)
C70.0239 (7)0.0266 (7)0.0215 (7)−0.0030 (5)−0.0030 (5)−0.0034 (5)
C80.0233 (7)0.0278 (7)0.0226 (7)−0.0029 (5)−0.0016 (5)−0.0108 (5)
C90.0211 (6)0.0232 (7)0.0290 (7)−0.0019 (5)−0.0038 (5)−0.0127 (6)
C100.0197 (6)0.0206 (6)0.0287 (7)−0.0021 (5)−0.0052 (5)−0.0089 (5)
C110.0185 (6)0.0179 (6)0.0273 (7)−0.0024 (5)−0.0042 (5)−0.0060 (5)
C120.0159 (6)0.0199 (6)0.0206 (6)−0.0030 (5)−0.0019 (5)−0.0058 (5)
C130.0175 (6)0.0209 (6)0.0241 (7)−0.0025 (5)−0.0030 (5)−0.0089 (5)
C140.0385 (8)0.0228 (7)0.0289 (7)−0.0018 (6)0.0008 (6)−0.0108 (6)
C150.0318 (8)0.0218 (7)0.0317 (8)−0.0016 (5)−0.0032 (6)−0.0053 (6)
C160.0307 (7)0.0295 (7)0.0246 (7)−0.0036 (6)0.0015 (6)−0.0053 (6)
C170.0320 (7)0.0270 (7)0.0165 (6)0.0022 (6)−0.0036 (5)−0.0045 (5)
O1—C111.3690 (15)C7—C81.3708 (19)
O1—C121.3746 (15)C7—H70.9500
O2—C91.2301 (15)C8—C131.3953 (18)
O3—C171.2225 (17)C8—H80.9500
O4—C171.3108 (16)C9—C101.4680 (19)
O4—H4O1.00 (2)C9—C131.4688 (18)
C1—C21.370 (2)C10—C111.3883 (18)
C1—C101.4032 (18)C12—C131.3925 (17)
C1—H10.9500C14—H14A0.9800
C2—C31.395 (2)C14—H14B0.9800
C2—H20.9500C14—H14C0.9800
C3—C41.3816 (19)C14—H14D0.9800
C3—H30.9500C14—H14E0.9800
C4—C111.4011 (19)C14—H14F0.9800
C4—C161.5030 (19)C15—H15A0.9800
C5—C61.3937 (18)C15—H15B0.9800
C5—C121.4031 (17)C15—H15C0.9800
C5—C141.5045 (18)C16—C171.505 (2)
C6—C71.4021 (19)C16—H16A0.9900
C6—C151.5057 (18)C16—H16B0.9900
Cg1···Cg2i3.491 (3)Cg2···Cg2i3.735 (3)
Cg1···Cg2ii3.591 (3)Cg2···Cg2ii3.639 (3)
C11—O1—C12119.45 (10)C12—C13—C9120.73 (12)
C17—O4—H4O109.3 (12)C8—C13—C9121.21 (11)
C2—C1—C10120.21 (13)C5—C14—H14A109.5
C2—C1—H1119.9C5—C14—H14B109.5
C10—C1—H1119.9H14A—C14—H14B109.5
C1—C2—C3120.06 (13)C5—C14—H14C109.5
C1—C2—H2120.0H14A—C14—H14C109.5
C3—C2—H2120.0H14B—C14—H14C109.5
C4—C3—C2121.64 (13)C5—C14—H14D109.5
C4—C3—H3119.2H14A—C14—H14D141.1
C2—C3—H3119.2H14B—C14—H14D56.3
C3—C4—C11117.33 (12)H14C—C14—H14D56.3
C3—C4—C16122.88 (13)C5—C14—H14E109.5
C11—C4—C16119.79 (12)H14A—C14—H14E56.3
C6—C5—C12117.71 (11)H14B—C14—H14E141.1
C6—C5—C14122.29 (11)H14C—C14—H14E56.3
C12—C5—C14120.00 (12)H14D—C14—H14E109.5
C5—C6—C7119.79 (12)C5—C14—H14F109.5
C5—C6—C15120.53 (11)H14A—C14—H14F56.3
C7—C6—C15119.67 (12)H14B—C14—H14F56.3
C8—C7—C6121.37 (12)H14C—C14—H14F141.1
C8—C7—H7119.3H14D—C14—H14F109.5
C6—C7—H7119.3H14E—C14—H14F109.5
C7—C8—C13120.32 (12)C6—C15—H15A109.5
C7—C8—H8119.8C6—C15—H15B109.5
C13—C8—H8119.8H15A—C15—H15B109.5
O2—C9—C10122.46 (12)C6—C15—H15C109.5
O2—C9—C13122.77 (12)H15A—C15—H15C109.5
C10—C9—C13114.77 (11)H15B—C15—H15C109.5
C11—C10—C1118.59 (12)C4—C16—C17113.59 (11)
C11—C10—C9120.20 (11)C4—C16—H16A108.8
C1—C10—C9121.21 (12)C17—C16—H16A108.8
O1—C11—C10122.88 (12)C4—C16—H16B108.8
O1—C11—C4114.95 (11)C17—C16—H16B108.8
C10—C11—C4122.17 (12)H16A—C16—H16B107.7
O1—C12—C13121.97 (11)O3—C17—O4123.02 (14)
O1—C12—C5115.28 (11)O3—C17—C16123.28 (12)
C13—C12—C5122.75 (12)O4—C17—C16113.68 (12)
C12—C13—C8118.06 (11)
C10—C1—C2—C3−0.5 (2)C16—C4—C11—O10.55 (18)
C1—C2—C3—C40.0 (2)C3—C4—C11—C10−0.25 (19)
C2—C3—C4—C110.4 (2)C16—C4—C11—C10−179.84 (12)
C2—C3—C4—C16179.95 (13)C11—O1—C12—C13−0.27 (17)
C12—C5—C6—C7−0.03 (18)C11—O1—C12—C5−179.83 (11)
C14—C5—C6—C7179.62 (12)C6—C5—C12—O1179.53 (11)
C12—C5—C6—C15−179.37 (12)C14—C5—C12—O1−0.13 (17)
C14—C5—C6—C150.28 (19)C6—C5—C12—C13−0.03 (19)
C5—C6—C7—C80.2 (2)C14—C5—C12—C13−179.69 (12)
C15—C6—C7—C8179.51 (12)O1—C12—C13—C8−179.58 (11)
C6—C7—C8—C13−0.2 (2)C5—C12—C13—C8−0.05 (19)
C2—C1—C10—C110.6 (2)O1—C12—C13—C90.23 (18)
C2—C1—C10—C9−179.11 (13)C5—C12—C13—C9179.75 (11)
O2—C9—C10—C11−179.09 (12)C7—C8—C13—C120.19 (19)
C13—C9—C10—C110.80 (17)C7—C8—C13—C9−179.61 (12)
O2—C9—C10—C10.6 (2)O2—C9—C13—C12179.41 (12)
C13—C9—C10—C1−179.46 (12)C10—C9—C13—C12−0.47 (17)
C12—O1—C11—C100.62 (17)O2—C9—C13—C8−0.8 (2)
C12—O1—C11—C4−179.77 (11)C10—C9—C13—C8179.32 (11)
C1—C10—C11—O1179.34 (12)C3—C4—C16—C17116.51 (15)
C9—C10—C11—O1−0.91 (19)C11—C4—C16—C17−63.93 (17)
C1—C10—C11—C4−0.24 (19)C4—C16—C17—O3−25.38 (19)
C9—C10—C11—C4179.51 (12)C4—C16—C17—O4155.89 (12)
C3—C4—C11—O1−179.87 (11)
D—H···AD—HH···AD···AD—H···A
O4—H4O···O3iii1.00 (2)1.63 (2)2.633 (1)173.25 (2)
C16—H16B···O4iv0.992.523.460 (1)158 (1)
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
O4—H4O⋯O3iii1.00 (2)1.63 (2)2.633 (1)173.25 (2)
C16—H16B⋯O4iv0.992.523.460 (1)158 (1)

Symmetry codes: (iii) ; (iv) .

  16 in total

1.  Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).

Authors:  Guanjun Cheng; Jing Sun; Zvi G Fridlender; Liang-Chuan S Wang; Lai-Ming Ching; Steven M Albelda
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

Review 2.  Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer.

Authors:  Mark J McKeage; Bruce C Baguley
Journal:  Cancer       Date:  2010-04-15       Impact factor: 6.860

3.  Vascular disrupting agents.

Authors:  John W Lippert
Journal:  Bioorg Med Chem       Date:  2006-10-27       Impact factor: 3.641

4.  1,7-Dihydr-oxy-2,3,4-trimeth-oxy-9H-xanthen-9-one monohydrate from Halenia elliptica.

Authors:  Peizhong Yu; Xiaojuan Shen; Changqi Hu; Edward J Meehan; Liqing Chen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-03-05

5.  Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m(2) combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer.

Authors:  Mark J McKeage; Martin Reck; Michael B Jameson; Mark A Rosenthal; David Gibbs; Paul N Mainwaring; Lutz Freitag; Richard Sullivan; Joachim Von Pawel
Journal:  Lung Cancer       Date:  2009-05-05       Impact factor: 5.705

6.  An improved synthesis of 5,6-dimethylxanthenone-4-acetic acid (DMXAA).

Authors:  Graham J Atwell; Shangjin Yang; William A Denny
Journal:  Eur J Med Chem       Date:  2002-10       Impact factor: 6.514

7.  A comparison of the ability of DMXAA and xanthenone analogues to activate NF-kappaB in murine and human cell lines.

Authors:  See-Tarn Woon; Charu B Reddy; Catherine J Drummond; Mary Ann Schooltink; Bruce C Baguley; Claudine Kieda; Lai-Ming Ching
Journal:  Oncol Res       Date:  2005       Impact factor: 5.574

8.  IFN-beta-dependent inhibition of tumor growth by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).

Authors:  Zachary J Roberts; Lai-Ming Ching; Stefanie N Vogel
Journal:  J Interferon Cytokine Res       Date:  2008-03       Impact factor: 2.607

Review 9.  Vascular disrupting agents in clinical development.

Authors:  P Hinnen; F A L M Eskens
Journal:  Br J Cancer       Date:  2007-03-20       Impact factor: 7.640

10.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.